Superworth

Stryker price to free cash flow SYK

Market value divided by free cash flow over the last twelve months, since 2010.

Today, Oct 23, 2026
25.1×
10-year median
39.9×
Against its 10-year history
1st
percentile: 0 is its lowest day, 100 its highest
10-year range
22.2× to 66.5×
Peer median
20.2×

Stryker's price to free cash flow is 25.1× as of Oct 23, 2026.

That is below its ten-year median of 39.9×, lower than on 99% of days in the last ten years.

Over that time it ranged from 22.2× in Sep 2026 to 66.5× in Apr 2018.

The median for 7 medical device stocks of a similar size is 20.2×.

Price to free cash flow over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far25.1×22.2×34.7×
202533.3×33.2×46.9×
202443.7×39.5×50.6×
202344.3×40.5×56.5×
202245.9×29.9×45.9×
202133.4×30.5×40.6×
202040.9×33.7×54.5×
201941.5×33.0×43.4×
201835.3×34.4×66.5×
201759.6×31.3×61.4×
201631.8×29.3×119×
201553.6×20.2×56.6×
201423.3×17.5×23.3×
201317.5×14.7×17.9×
201214.2×13.5×20.2×
201117.2×15.4×19.4×
201015.2×11.9×17.1×

Against its peers

Companies in Medical - Devices nearest Stryker's size, closest first, today.

CompanyPrice to free cash flow
SYKStryker25.1×
MDTMedtronic19.9×
ABTAbbott Laboratoriesn/m
BSXBoston Scientific18.3×
EWEdwards Lifesciences35.8×
GEHCGE HealthCare Technologies20.4×
DXCMDexCom20.9×
ZBHZimmer Biomet12.3×
Peer median20.2×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Stryker

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.